On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
July 26, 2026 Giant sequoias are built to withstand ordinary fires, but recent extreme wildfires killed thousands of trees that had survived for centuries or even millennia. A new analysis of about 26 ...
DeadLock ransomware: Breaking down a Rust-based encryptor with decentralized recovery infrastructure
Microsoft Threat Intelligence examines DeadLock ransomware, an emerging financially motivated operation distinguished by its ...
Microsoft's seventh .NET 11 preview expands runtime-async, developer tooling, libraries, C#, Blazor, MAUI, EF Core and Windows Forms.
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Access detailed historical stock prices, including daily closing prices, for RXRX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results